About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

How Potential Diabetes Drugs Interact With Their Target

by Dr. Trupti Shirole on December 8, 2016 at 11:44 PM
Font : A-A+

 How Potential Diabetes Drugs Interact With Their Target

LRH-1 (liver receptor homolog-1) is a nuclear receptor, a type of protein that turns on genes in response to small molecules like hormones or vitamins. LRH-1 acts in the liver to regulate metabolism of fat and sugar.

Biochemist Eric Ortlund and colleagues have obtained analogous results in their study of how potential diabetes drugs interact with their target, the protein LRH-1. Their research, published in Journal of Biological Chemistry, shows that making small changes to LRH-1-targeted compounds makes a big difference in how they fit into the protein's binding pocket.

Advertisement


This research was selected as "Paper of the Week" by JBC and is featured on the cover of the December 2, 2016, issue.

Previous research has shown that activating LRH-1 decreases liver fat and improves insulin sensitivity in mice. Because of this, many research teams have been trying to design synthetic compounds that activate this protein, which could have potential to treat diabetes and nonalcoholic fatty liver disease. This has been a difficult task, because not much is known about how synthetic compounds interact with LRH-1 and switch it into the active state.
Advertisement

Ortlund lab researchers used X-ray crystallography to explore in detail how the LRH-1 protein interacts with two closely related LRH-1 activators, previously identified by collaborators at the University of Southampton, UK.

The first author of the paper is Suzanne Mays, a graduate student in Emory's Molecular and Systems Pharmacology program. Ortlund is associate professor of biochemistry at Emory University School of Medicine. Nathan Jui, from Emory's Department of Chemistry and scientists at Scripps Research Institute in Florida also contributed to the paper.

"We were surprised to find two synthetic activators that are structurally very similar to each other interacting with LRH-1 completely differently," Mays says. "They can rotate nearly 180 degrees relative to each other in the binding pocket. This may explain why small changes to this class of molecule had unpredictable effects in previous studies."

The authors discovered a new interaction made by one of the compounds that has potential to serve as an "anchor point" to keep the compound in place. This will help researchers make compounds that better fit in the "lock" without worrying about them rotating around unpredictably. In collaboration with Jui's lab, the Ortlund lab is continuing to fine-tune the design of LRH-1 activators.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide 

Most Popular on Medindia

Iron Intake Calculator Indian Medical Journals A-Z Drug Brands in India Noscaphene (Noscapine) Find a Hospital Hearing Loss Calculator Pregnancy Confirmation Calculator Blood Donation - Recipients Sinopril (2mg) (Lacidipine) Vent Forte (Theophylline)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

How Potential Diabetes Drugs Interact With Their Target Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests